NCT07529717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07529717
Title First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer (CRIUS-1)
Acronym CRIUS-1
Recruitment Not yet recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.